-
Online Pharmacy's TOP10 Blood Lipid-lowering Drug Products Released
According to the latest data from Minet.com, in 2021, the sales of terminal blood lipid regulator chemical drugs in China's online pharmacies will be ...
2022-05-18 17:54 -
Emerging Industry of Medical-grade PCs Global Medical Market Expected to Generate $336 Billion in Re...
China's medical device market reached RMB 164.4 billion in 2010, up 16.2% year-on-year. With the steady development of China's national economy and th...
2022-05-17 17:43 -
Anke Bio and Afana Collaborate on mRNA Vaccines for Mutant Strains Such as COVID-19 Omicron
On May 16, Anke Bio announced that the company and Afana recently signed a formal "cooperation agreement", and reached a consensus on the development ...
2022-05-17 17:37 -
Sanofi's Sarclisa Combination Therapy has Significant Efficacy in the Treatment of Multiple Myeloma
Recently, Sanofi announced the latest results of the Phase 3 IKEMA clinical trial. The trial is evaluating the addition of the CD38-targeting antibody...
2022-05-17 17:30 -
FDA Approves New Oral Therapy to Delay Functional Decline of ALS by 33%
On the 14th, Mitsubishi Tanabe Pharma America (MTPA) announced that the U.S. FDA has approved the marketing of oral edaravone (edaravone, English bran...
2022-05-16 17:52 -
As Low as $25/session! Pfizer's COVID-19 Oral Drug Paxlovid Generic Drug Price Released
Recently, the Clinton Health Access Initiative (CHAI) disclosed that several generic drugmakers producing Pfizer’s covid-19 oral antiviral drug Paxlo...
2022-05-16 16:28 -
Novartis Sandoz Launches First Esbriet Generic in US
A few days ago, Sandoz officially announced the launch of the first generic version of Esbriet in the United States for the treatment of patients with...
2022-05-16 16:12 -
With US$50.5 Million, Henlius Joins Hands With Brazilian Leader to Enter 16 Latin American Countries
On May 11, Henlius signed a license agreement with Eurofarma, a leading domestic pharmaceutical company in Brazil, granting it to the company's self-d...
2022-05-13 17:29 -
Merck's New Antiviral Drug 'Litemovir Injection' Approved for Marketing in China
Today, the official website of China's National Medical Products Administration (NMPA) announced that Merck's (MSD) new antiviral drug letermovir inje...
2022-05-13 16:08 -
BMS Over $900 Million to Help Develop Potential 'Best-in-class' SHP2 Inhibitors
BridgeBio Pharma announced today that it has entered into an agreement with Bristol-Myers Squibb to co-develop and commercialize a potential "best-in-...
2022-05-13 13:52
Hot News
- ExxonMobil Launches $10 Billio... Jul 17, 2025
- Global MDI/TDI Plants Enter Pe... Jul 23, 2025
- Europe Faces Unprecedented Pet... Jul 23, 2025
- Sally Beauty Acquires Flair Ha... Jul 07, 2025
- Guangdong Jieyang Puts into Op... Jul 16, 2025
Related Products
Related Producers
